Method and compositions for suppression of atherogenesis utilizi

Details Method and compositions for suppression of atherogenesis utilizi Method and compositions for suppression of atherogenesis utilizi

1987-02-18

1988-12-06

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514824, A61K 3156

Patent

active

047896701

ABSTRACT:
Atherogenesis is suppressed by administering cholesterol hydroperoxide in an amount effective for reducing aortal deposit of cholesterol. The cholesterol hydroperoxide may be administered in an oral dose form.

REFERENCES:
J. Org. Chem., vol. 38, No. 1 (1973), pp. 119-123; Teng et al.
J. Org. Chem., vol. 35, No. 8 (1970), pp. 2627-2632; VanLier et al.
Chemical Abstracts, vol. 106 (1987), #3176k; Highley et al.

Affiliated with

Also associated with

Rating

Method and compositions for suppression of atherogenesis utilizi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and compositions for suppression of atherogenesis utilizi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions for suppression of atherogenesis utilizi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1494207